L1CAM and endometrial cancer: To conclude, most L1CAM studies in endometrial cancer are retrospective, often spanning long periods with different treatments, and they are based on different immunohistochemical techniques—different automated systems, different antibodies, different cutoffs, and probably pathologist interpretation-based expected biases.